Researchers used magnesium particles as tiny motors to deliver an oral vaccine against the bacterial pathogen Staphylococcus aureus.

A study funded by the National Institutes of Health has created a virtual library expected to expand the availability of “make-on-demand” molecules for drug discovery.

Honeywell introduces Aclar Accel barrier film with faster production and delivery for pharma packaging.

The agency is requiring companies that make sartan blood pressure drugs to review their manufacturing processes due to the problem with impurities.

PCI Pharma Services expanded capacity of its commercial packaging site in Illinois.

The agency recommended six medicines for approval at its January 2019 meeting, including treatments for lung cancer, HIV-1, and autoimmune disorders.

The companies will develop Amprologix’s lead epidermicin-based antibiotic candidate.

The company will open its first European manufacturing facility in Castlebar, Ireland.

The US Pharmacopeial Convention’s new plan will include new and revised quality standards and activities to support the development of new generic drugs.

A solid lipid excipient from ABITEC is designed for multiple dosing forms.

A new reactor flask heating system now offered by Asynt allows the conduction of safe experiments in academic teaching and research labs.

Keeping abreast of the latest industry trends and retaining flexibility are key to maintaining a strong market position.

New HHS proposal would remove the current safe harbor protection from the federal Anti-Kickback Statute for rebates or discounts provided to Medicare Part D drug plans and certain state Medicaid programs.

Company launches new services dedicated to emerging biotech and biopharma companies.

As we approach the next instalment of Pharmapack Europe, a potentially perilous situation in relation to drug packaging has emerged for pharmaceutical companies should Brexit result in a ‘no deal’ scenario.

Biosimilars, pricing strategies, and technology will influence growth in spending on drugs.

Political instability is causing uncertainty in Europe and wreaking havoc with US regulatory timeframes.

Various groups and stakeholders from pharma, healthcare, and government are responding to a new draft environmental risk assessment guidance from EMA.

A new initiative has been launched to help stimulate industry discussion on innovative tech for use across the drug supply chain.

Pharmapack Europe event organizers have released a report titled, ‘European drug delivery and packaging’ that forecasts an increase in innovation from smaller European companies.

The ABPI has released a statement calling for action to address skills shortages in science within the UK, which could jeopardize the country’s position for medicines and vaccines R&D.

Validair Monitoring Solutions has secured new funding that will be used to support the growth of the company across the UK.

ChargePont Technology has revealed that it is now able to expand its smart monitoring technology into North America thanks to being granted HazLoc (Hazardous Area) certification.

A Memorandum of Understanding (MoU) has been signed by the UK’s MHRA and the State Institute of Drugs and Good Practices of the Ministry of Industry and Trade of the Russian Federation.

TrakCel and WindMIL Therapeutics have formed a partnership to build a custom-configured cellular supply chain tracking and orchestration platform.

Sphere Fluidics has closed its latest investment round in which it raised US$2 million (approximately £1.5 million).

The acquisition will boost Hitachi Chemical’s presence in the European regenerative medicines market.

Janssen and MeiraGTx will collaborate on the development and commercialization of gene therapies for treating inherited retinal diseases.